1. Introduction {#sec1}
===============

Obesity is a worldwide epidemic leading to disorders such as hypertension, Type 2 diabetes, cardiovascular diseases and non-alcoholic fatty liver disease ([@bib42]). At least 2.8 million adults die due to being overweight or obese each year ([@bib40]). Globally, over 1.9 billion adults were overweight while more than 650 million adults were obese in 2016 ([@bib40]). In Australia, a total of 67% of adults were overweight, in which 31.3% were obese in 2017--2018 ([@bib3]).

A promising strategy for weight reduction is to suppress nutrient digestion and absorption ([@bib5]; [@bib33]; [@bib37]). Pancreatic lipase (PL), a known enzyme playing a crucial role in lipolysis, promotes fatty acids absorption in the small intestine ([@bib5]; [@bib21]). Orlistat is a known effective pancreatic lipase inhibitor that has been used for the long-term weight management since 1999 ([@bib21]; [@bib33]). However, it can lead to gastrointestinal intolerances, including faecal urgency and faecal incontinence ([@bib9]; [@bib20]; [@bib33]). Hence, greater attention has been drawn to herbal medicine due to their potentials for offering novel, weight-loss treatments. However, scientific validation is required to validate these claims for the use of these popular products ([@bib22]).

The RCM-107 formula (granule) has been modified from our previous studied RCM-104 formula which demonstrated significant weight reduction in the clinical trial ([@bib17]) by adding additional herbs known to contain weight-loss bioactive compounds. This formula contains eight Chinese herbs, including *Camellia sinensis* (green tea), *Poria*, *Nelumbinis folium* (lotus leaf), *Alismatis rhizoma*, *Plantaginis semen*, *Cassiae semen*, *Sophorae flos* and *Gardeniae fructus*. The active components for weight reduction or lipase inhibition from the individual crude herbs presenting in the RCM-107 formula have been previously described in the scientific literature. Tea catechins such as EGCG, ECG, EC and (+)-catechin have been reported to play important roles in weight reduction ([@bib24]). For example, [@bib13a] studied the pancreatic lipase inhibition effects of EGCG, which is the most active and abundant compound found in green tea ([@bib8]; [@bib24]). Caffeine from green tea can reduce weight by increasing energy expenditure *via* promoting lipid oxidation and thermogenesis ([@bib29]).

In addition, [@bib23] indicated that *Alismatis rhizoma* contains triterpenoids (such as alisol B acetate) as the main bioactive compound that can reduce serum total cholesterol and triglycerides levels. Anthraquinones, in particular, chrysophanol ([@bib19]), has been considered as one of the main bioactive ingredients present in *Cassia semen* that may be responsible for its lipid-lowering activities ([@bib4]). In a study by [@bib35], the authors found that crocin present in *Gardeniae fructus* can be used as an effective anti-hyperlipidemic agent as it could interfere with pancreatic lipase activity and contribute to the reduction in lipid absorption. Furthermore, [@bib2] and [@bib13] suggested that flavonoids such as quercetin and rutin from lotus leaves and *Sophorae flos* are beneficial for suppressing fat accumulation. Quercetin-3-*O*-D-glucuronide (Q3*O*G), is one of the flavonoids in lotus leaves and has also shown strong inhibitory effects of porcine pancreatic lipase ([@bib2]).

To our best knowledge, there has been no published research investigated the effects of the RCM-107 formula on the weight-loss target pancreatic lipase. In this study, we aim to explore the lipase inhibitory activities of the modified herbal formula and respective individual herbs, as well as identify the presence of the bioactive weight-loss compounds mentioned earlier in the formula. The interactions between potential lipase inhibitors (chemical compounds) to the target enzyme (pancreatic lipase) were determined to identify likely mechanistic interactions for ligand-target binding.

2. Methods {#sec2}
==========

2.1. Materials {#sec2.1}
--------------

Lipase from porcine pancreas (type VI-S L0382-100KU), orlistat (04139-25 mg) and 4-methylumbelliferyl oleate (4-MUO 75164-25 mg) were obtained from Sigma-Aldrich Australia. Chemical references EGCG, ECG, EC, caffeine, rutin, crocin, solvents used for high-performance thin layer chromatography (HPTLC) mobile phase (i.e. toluene, acetone, formic acid, ethyl acetate, glacial acetic acid, chloroform, methanol and ethanol), derivatization reagents: Fast Blue Salt B, Natural Products Reagent (NP reagent), Polyethylene glycol (PEG solution), 10% sulphuric acid reagent and *p*-anisaldehyde-sulfuric acid reagent were also purchased from Sigma-Aldrich, Australia. The RCM-107 capsules (AUST L 285569) were obtained from Tong Kang Lee Chinese medicine clinic and single herbal granules (extracted products) of Fu ling/*Poria*, He Ye/lotus leaf, Ze Xie/*Alismatis rhizoma*, Che Qian Zi/*Plantaginis semen*, Jue Ming Zi/*Cassiae semen*, Huai Hua/*Sophorae flos*, Zhi Zi/*Gardeniae fructus*, green tea (matcha) were supplied by GL natural health care Chinese medicine clinic. HPTLC glass plates 20 × 10 cm coated with silica gel 60 F~254~ were produced by Merck. Chromatographic equipment (Linomat 5 sample applicator; ADC 2 developing chamber; automated derivatizer; visualizer; VisionCATS 2.4 software) were supplied by CAMAG. Molecular docking was conducted via virtual screening software PyRx (Version 0.8).

2.2. Lipase inhibition assay {#sec2.2}
----------------------------

### 2.2.1. Herbal extraction {#sec2.2.1}

Individual capsule of RCM-107 containing 500 mg herbal powder was mixed with starch. All concentrated herbal powders and granules were obtained by water extraction of the raw materials via boiling and lyophilisation performed by the manufacturer. Twenty milligrams of the RCM-107 herbal powder and the eight individual herbal granules were weighed and dissolved in 4 mL of Milli-Q® Water (Merck Millipore Milli-Q® Integral Water Purification System) mixed with 2% dimethyl sulfoxide (DMSO). The samples were subsequently vortexed and sonicated for 10 min then microfiltered through a Millex-HP 0.45μm filter (Millipore). Dilution from the stock solution (5 mg/mL) was performed to achieve a final concentration of 0.1 mg/mL. In addition, serial dilution of the RCM-107 formula was performed to obtain seven point calibration of this sample (0.001--0.3 mg/mL).

### 2.2.2. Measurement of pancreatic lipase activity {#sec2.2.2}

The fluorometric assay of pancreatic lipase activity using 4-MUO as a substrate was carried out according to the modified methods previously described by [@bib25] and [@bib27]. Twenty-five microliters of the RCM-107 formula sample solution (0.001--0.3 mg/mL), each single herbal granule (0.1 mg/mL), 25 μL of the lipase solution (50 U/mL) were prepared in buffer (13 mM Tris-HCl, 75 mM NaCl 1.3 mM CaCl~2~ pH 8.0) and pre-incubated at room temperature for 5 min. To initiate the enzyme reaction, 50 μL of 0.1 mM 4-MUO solution was dissolved in the same buffer as described above and was added to the pre-incubation mixture followed by incubation for an additional 30 min at room temperature. The amount of 4-methylumbelliferone produced was measured with a *CLARIOstar*® microplate reader (BMG labtech) using an excitation and emission wavelength of 355 nm and 460 nm, respectively. Orlistat (a pancreatic lipase inhibitor) was included in each test as a positive control. Wells that contained either samples and buffer or enzyme and buffer were used to detect background autofluorescence. The inhibition activity (%) of the pancreatic lipase was calculated using the following equation:

F~sample~ and F~sample\ background~ represent fluorescence values of the sample solution with or without substrate, while F~control~ and F~control\ background~ are fluorescence values of the control (no inhibitors) with or without substrate, respectively. F~blank~ is the fluorescence value of the chosen blank, which consists of substrate and buffers only.

### 2.2.3. Statistical analysis {#sec2.2.3}

Samples and controls were all run in triplicates. Results were presented as mean ± SEM from three independent experiments. The concentration providing 50% inhibition (IC~50~) was calculated by non-linear regression (values are mean ± SD) and statistical significance was assessed with one-way analysis of variance (ANOVA) followed by the Tukey multiple comparison tests via GraphPad Prism 7 software. Results with *P* \< 0.05 have been considered statistically significant.

2.3. High-performance thin-layer chromatography {#sec2.3}
-----------------------------------------------

### 2.3.1. Sample and standard extraction {#sec2.3.1}

The RCM-107 formula (0.5 g) was individually mixed with 10 mL of either ethanol; methanol; ethanol-water 8:2, methanol-water 8:2 and ethyl acetate. Single granules such as green tea powder (0.4 g) were mixed with 4 mL ethanol while lotus leaf granules (0.4 g) were mixed with 4 mL methanol. Granules of *Cassia semen* (1 g), *Gardeniae fructus* (1 g), *Sophorae flos* (1 g) were prepared in 10 mL of methanol and *Alismatis rhizoma* (1 g) was dissolved in 10 mL of ethyl acetate. All samples were vortex-mixed for 2 min and centrifuged at 4000 rpm for 10 min. The supernatants were obtained for HPTLC profiling.

Chemical standards of EGCG, ECG, EC and caffeine were individually dissolved in methanol to prepare stock solutions and subsequently, serially diluted to achieve a final concentration of 10 μg/mL. Quercetin, rutin and Q3*O*G were prepared in ethyl acetate individually prepared stock solutions and subsequently, serially diluted to make a final concentration of 100 μg/mL. Crocin was mixed in a 1:1 methanol-water to obtain a stock solution (1 mg/mL) and subsequently, serially diluted to 100 μg/mL. Chrysophanol and alisol B acetate were prepared in ethyl acetate to prepare stock solutions and subsequently, serially diluted to yield a final concentration of 10 μg/mL and 100 μg/mL, respectively.

### 2.3.2. Chromatography {#sec2.3.2}

Herbal samples (2 μL) and reference standards (5--20 μL) were applied to the plates as 6--8 mm bands, 7.8--11.4mm apart via Linomat 5 sample applicator from CAMAG. Dosage speed varied from 75 nL/s-150 nL/s depending on the type of solvents used. Plates were developed to a distance of 70 mm in the pre-saturated (25 min) and pre-drying was carried out in an ADC 2 developing chamber (a twin trough chamber) ([@bib31]).

### 2.3.3. Derivatization {#sec2.3.3}

Polyphenols (EGCG, ECG and EC): 2.0 mL of Fast Blue Salt B reagent was sprayed over the plate. Evaluation was performed under white light or UV 254 nm ([@bib34]). Flavonoids (quercetin, rutin and Q3*O*G): 2.0 mL of NP reagent was sprayed over the plate, with a 5 min delay, then 2.0 mL of PEG solution was sprayed. Evaluation was performed under UV 366 nm ([@bib34]). Crocin: no derivatization was required. Evaluation was performed under white light after development ([@bib39]). Anthraquinones (chrysophanol): 2.0 mL of 10% sulphuric acid reagent was sprayed over the plate, followed by heating of the plate at 100 ^ͦ^ C for 3 min. Evaluation was performed under UV 366 nm ([@bib28]). Triterpenoid (alisol B acetate): 2.0 mL of *p*-anisaldehyde-sulfuric acid reagent was sprayed over the plate, and the plate was heated at 100 ^ͦ^ C for 3 min, followed by evaluation under white light ([@bib39]).

### 2.3.4. Documentation {#sec2.3.4}

Images of the plates were taken before or after development and after derivatization under white light, UV254 nm and UV366 nm via the visualizer. Reports were generated using Vision CATS 2.4 software ([@bib31]).

### 2.3.5. Compound identification {#sec2.3.5}

HPTLC profiling was used as a rapid tool purely to efficiently identify the nominated compounds by comparing the system suitability parameter (*Rf* values) of the authentic standards to that either present or absent in the tested sample ([@bib16]; [@bib32]). In all cases, the mobile phases were optimized prior to chromatographic separation ([@bib16]).

The herbal samples were extracted using different solvents to ensure the efficient extraction of compounds from the samples. The experiments were repeated in six independent analyses to ensure accuracy and repeatability ([@bib16]).

2.4. Molecular docking {#sec2.4}
----------------------

The published three-dimensional (3D) structure of pancreatic lipase (PDB code:[1ETH](pdb:1ETH){#intref0010}, a dimer) was acquired from the RCSB protein databank, which was modified using the program Visual Molecular Dynamics (VMD) to obtain protein-only structures ([@bib10]). Structures of the weight-loss or lipid inhibiting compounds presented in the HPTLC experiments were downloaded from PubChem (<https://pubchem.ncbi.nlm.nih.gov/>). Both selected protein and ligand files were loaded to PyRx as macromolecules and ligand, respectively. The reference protein and ligands were placed inside an enclosed box with 'centre' X: 8.3130; Y: 73.5614; Z: 146.1870 and 'dimensions' X: 58.2669; Y: 72.8369; Z: 57.5022, followed by docking process initiated via the AutoDock Vina from PyRx. The exhaustiveness was set as 64. The binding affinity scores were recorded using Microsoft Excel. Two-dimensional (2D) and 3D interactions between the ligands and protein were observed from Discovery Studio Visualizer (DSV).

3. Results {#sec3}
==========

3.1. In vitro inhibition of pancreatic lipase {#sec3.1}
---------------------------------------------

The effects of the RCM-107 formula, 8 single herbal granules present in the modified formula included *Poria*, lotus leaf, *Alismatis rhizoma*, *Plantaginis semen*, *Cassiae semen*, *Sophorae flos*, *Gardeniae fructus*, green tea and the positive control orlistat on porcine pancreatic lipase were examined ([Fig. 1](#fig1){ref-type="fig"}). All samples were screened at a concentration of 100 μg/mL and lipase activity was presented as a percentage of the control (with no inhibitor). Four herbal samples displayed potent inhibitory effects than the known inhibitor, orlistat whilst green tea exhibited the highest inhibition rate of 89 % which was slightly but non-significantly higher than that of the RCM-107 formula (88 %) (*P* \> 0.05). *Sophorae flos* and *Gardeniae fructus* displayed an average inhibition level of 80 % and 74 %, respectively whereas orlistat showed a 73% inhibition of lipase. The differences in inhibition between green tea, the RCM-107 formula and orlistat were considered as statistically significant (*P* \< 0.05).Fig. 1Suppressive effects of the RCM-107 formula, eight single herbal granules and orlistat (inhibitor) at 100 μg mL^−1^ on pancreatic lipase activity. The lipase activity with an absence of the samples or inhibitor was presented as 100%. Data is expressed as means ±SEM from three independent experiments, including three replicates each time. \*\*\*\* indicates *P* \< 0.0001 as compared to the control, R square: 0.983.Fig. 1

Lipase inhibitors which showed minimal potency were also identified. Lotus leaf, *Alismatis rhizoma* and *Cassiae semen* significantly reduced lipase activity with inhibition rates of 68 %, 55 % and 46 %, respectively (*P* \< 0.0001). The two herbal granules *Poria* and *Plantaginis semen* were found to display mild inhibitory activities (10% and 8%) compared to the control, however, the differences were statistically insignificant (*P* \> 0.05).

Additionally, the RCM-107 formula was assayed using a seven-point calibration curve, which displayed inhibitory effects in a dose-dependent manner ([Fig. 2](#fig2){ref-type="fig"}). This herbal formula presented potent pancreatic lipase inhibitory activities with an IC~50~ value of 7.17 ± 0.69 μg/mL (mean ± SD). The enzyme activity was dramatically suppressed when the concentration of the RCM-107 formula increased from 1 μg/mL to 300 μg/mL, which exhibited an inhibition rate from 8% to 93%, respectively.Fig. 2Dose-dependent inhibitory effects of the RCM-107 formula (1-300 μg mL^−1^) on porcine pancreatic lipase. Data represent mean ± SEM from three independent experiments with three replicates per condition.Fig. 2

3.2. HPTLC {#sec3.2}
----------

### 3.2.1. Method specificity {#sec3.2.1}

Authentic standards at different concentrations were applied in each chromatography plate, including 0.05, 0.1, 0.15, 0.2 μg/spot of EGCG, ECG, EC, caffeine and chrysophanol; 0.5, 1, 1.5 μg/spot of quercetin, rutin, Q3*O*G and crocin; 0.5, 1, 1.5, 2 μg/spot alisol B acetate. Optimized concentrations of herbal samples were carried out in all experiments, including 0.1 mg/spot of RCM-107 formula; 0.2 mg/spot of green tea; lotus leaf; *Cassia semen*; *Gardeniae fructus***;** *Sophorae flos* and *Alismatis rhizome*.

Varying compositions and ratios of toluene, acetone, formic acid for separating caffeine and polyphenols such as EGCG, ECG, EC; ethyl acetate, formic acid, glacial acetic acid, water for flavonoids like quercetin, rutin and Q3*O*G; chloroform, methanol, water for crocin; ethyl acetate, methanol, water for chrysophanol; chloroform, methanol, water for alisol B acetate were examined. The optimized forms of mobile phase were adjusted and used in the experiments.

### 3.2.2. Identification of EGCG, ECG, EC and caffeine {#sec3.2.2}

HPTLC fingerprints were generated for the RCM-107 formula and green tea samples, which were developed on silica gel using the mobile phase toluene, acetone, formic acid 9:9:2 (v/v/v) ([@bib34]). After derivatization with Fast Blue Salt B reagent ([@bib34]), all polyphenols were readily identified under white light. EGCG, ECG and EC with increasing *Rf* values (0.35, 0.46 and 0.54, respectively) were used as authentic standards ([Fig. 3](#fig3){ref-type="fig"}). In addition, caffeine displayed an *Rf* value of 0.523 under 254 nm (UV light) after development but without derivatization ([Fig. 4](#fig4){ref-type="fig"}). All four polyphenols were identified in the RCM-107 formula and green tea samples, except in the lotus leaf sample by comparison of the *Rf* of the authentic standard to that identified in the samples.Fig. 3HPTLC fingerprint (polyphenols) of herbal samples under white light after derivatization. 1--12: chemical reference substances: EGCG, ECG, EC in different volumes (5--20 μL), respectively; 13: the RCM-107 formula in methanol; 14: the RCM-107 formula in ethanol; 15: green tea sample; 16: Lotus leaf sample.Fig. 3Fig. 4HPTLC fingerprint (caffeine) of herbal samples after development under UV 254 nm. 1--4: chemical reference caffeine in different volumes (5--20 μL); 5: the RCM-107 formula in methanol; 6: the RCM-107 formula in ethanol; 7: green tea sample; 8: Lotus leaf sample.Fig. 4

### 3.2.3. Identification of quercetin, rutin and Q3*OG* {#sec3.2.3}

HPTLC fingerprints of flavonoids were identified in the RCM-107 formula, *Sophorae flos* and lotus leaf samples which were developed on silica gel using the mobile phase ethyl acetate, formic acid, glacial acetic acid, water 100:11:11:27 (v/v/v) ([@bib34]). Following chemical derivatization with NP reagent first followed by the PEG solution ([@bib34]), all 3 flavonoids were observed under 366 nm quercetin, rutin and Q3*O*G with increasing *Rf* values (0.96, 0.41 and 0.52, respectively) were used as authentic standards ([Fig. 5](#fig5){ref-type="fig"}). Only rutin was identified to be present in the RCM-107 formula. Both quercetin and rutin could be identified in the *Sophorae flos* sample while Q3*O*G was identified exclusively in the lotus leaf sample by comparison of the *Rf* of the authentic standard to that identified in the samples.Fig. 51--3: reference substance: quercetin (5--15μL); 4--5: reference substance:rutin (5--15μL); 7--9: reference substance: quercetin-3-*O*-D-glucuronide (5--15μL); 10: the RCM-107 formula in methanol-water 8:2; 11: the RCM-107 formula in ethanol-water 8:2; 12: the RCM-107 formula in ethyl acetate; 13: the RCM-107 formula in methanol; 14: the RCM-107 formula in ethanol; 15:*Sophorae flos* sample; 16: Lotus leaf sample.Fig. 5

### 3.2.4. Identification of crocin {#sec3.2.4}

HPTLC fingerprints of crocin were identified in the RCM-107 formula and *Gardeniae fructus* sample which were developed on silica gel using the mobile phase chloroform, methanol, water 70:30:4 (v/v/v) ([@bib39]). No derivatization was required, and results were observed under white light. Crocin gave an *Rf* value of 0.1 as the authentic standard ([Fig. 6](#fig6){ref-type="fig"}). Crocin was found to be present in the RCM-107 formula and *Gardeniae fructus* samples by comparison of the *Rf* of the authentic standard to that identified in the samples.Fig. 61--3: reference substance Crocin (5--15μL); 5: the RCM-107 formula in methanol-water 8:2; 6: the RCM-107 formula in methanol; 7: the RCM-107 formula in ethanol; 8: *Gardeniae fructus* samples.Fig. 6

### 3.2.5. Identification of chrysophanol {#sec3.2.5}

According to the literature, cassia seed should contain chrysophanol ([@bib28]). Samples and standards were developed on silica gel using the mobile phase ethyl acetate, methanol, water 80:20:10 (v/v/v) ([@bib28]). Sulphuric acid (10%) reagent was used as the chemical derivatising agents and the results were evaluated under 366nm after derivatization. Chrysophanol gave an *Rf* value of 0.86 was used as an authentic standard ([Fig. 7](#fig7){ref-type="fig"}). However, both the RCM-107 formula and cassia seed samples showed no trace of chrysophanol under these conditions.Fig. 71--4: reference substance chrysophanol (5--20μL); 5: the RCM-107 formula in methanol; 6: the RCM-107 formula in ethanol; 7: Cassia seed sample.Fig. 7

### 3.2.6. Identification of alisol B acetate {#sec3.2.6}

According to the literature, *Alismatis rhiazoma* should contain alisol B acetate ([@bib39]). Samples and standards were developed using the mobile phase chloroform, methanol, water 70:30:4 (v/v/v) ([@bib39]) and derivatized with *p*-anisaldehyde-sulfuric acid reagent ([@bib39]). Alisol B acetate gave an *Rf* value of 0.92 after derivatization under white light as the authentic standard ([Fig. 8](#fig8){ref-type="fig"}). However, no alisol B acetate was detected in the RCM-107 formula or *Alismatis rhiazoma* samples.Fig. 81--4: chemical reference substance alisol B acetate (5--20μL); 5: the RCM-107 formula in methanol; 6: the RCM-107 formula in ethanol; 7: *Alismatis rhiazoma* sample.Fig. 8

3.3. Molecular docking {#sec3.3}
----------------------

In total seven ligands were selected for molecular docking, including the positive control, orlistat and the compounds identified in the HPTLC profiling experiments. Molecular docking was performed to study the interactions between the target (PDB code: [1ETH](pdb:1ETH){#intref0020}) and ligands (orlistat, EGCG, ECG, EC, caffeine, crocin and rutin).

A greater negative numerical value binding affinity indicates a firmer predicted binding in the ligand-target complex. The molecular docking results demonstrated that crocin had the highest binding affinity (-10 kcal/mol) to the 1ETH, followed by EC, EGCG, ECG (-9.6, -9.5 and -9.4 kcal/mol, respectively). On the other hand, rutin, the positive control orlistat and caffeine had the lowest binding energy (-8.7, -7.6 and -6.6 kcal/mol, respectively) compared to the others ([Table 1](#tbl1){ref-type="table"}). The majority of the selected ligands displayed stronger predicted binding affinity than the known lipase antagonist, orlistat.Table 1Binding affinity and hydrogen bonding of the ligands presented in HPTLC with pancreatic lipase (1ETH).Table 1Herbal namesLigandsBinding affinity (kcal/mol)Conventional hydrogen bond (Amino acid)Bond length (Å)Green teaEGCG-9.5TYR115(Chain A)5.51HIS152(Chain A)4.38ASP80(Chain A)3.58Green teaECG-9.4HIS152(Chain C)4.41GLY77(Chain C)3.07Green teaEC-9.6GLY77(Chain A)3.17Green teaCaffeine-6.6ARG257(Chain C)4.12Lotus Leaf/*Sophorae flos*Rutin-8.7GLU303(Chain C)5.49VAL322(Chain C)5.49ASN320 ((Chain C,2 BONDS)4.61; 3.13*Gardeniae fructus*Crocin-10GLN220 (Chain C)5.13GLN220 (Chain A)4.94GLN22(Chain C)5.66VAL21(Chain A)3.93VAL21(Chain C)4.11GLU188 (Chain C)4.33ARG191(Chain A)6.48Lipase inhibitorOrlistat-7.6GLY77(Chain A)3.26HIS152(Chain A)4.28ASP80(Chain A)4.29SER153(Chain A)4.64

There are two identical chains of 1ETH, the best binding mode of EGCG, EC and the orlistat located on the same chain of the target 1ETH ([Fig. 9](#fig9){ref-type="fig"}). Only 1 hydrogen bond interaction (3.17Å) was formed between the phenolic hydrogens and oxygen of EC ([@bib36]) and the residue GLY77 while 3 hydrogen bonds with distances of 5.51 Å, 4.38 Å, and 3.58 Å, respectively; established with the side chains of TYR115, HIS152, and ASP80 for EGCG. In addition, orlistat formed 4 hydrogen bonds (3.26, 4.28, 4.29, 4.64 Å, respectively) with GLY77, HIS152, ASP80, SER153 ([Table 1](#tbl1){ref-type="table"}).Fig. 93D image showing the best binding mode of orlistat (yellow), EGCG (orange), EC (grey and red), crocin (green), rutin (blue), ECG (pink), caffeine (purple) within the porcine pancreatic lipase (PDB code: IETH).Fig. 9

On the other chain of 1ETH, ECG was found to form hydrogen bonds with amino acid residues HIS152 and GLY77 (4.41 and3.07 Å, respectively). Caffeine formed 1 hydrogen bond with the residue ARG257 with a distance of 4.12 Å. In total four hydrogen bonds with amino acids GLU303, VAL322, ASN320 (2 bonds) (5.49, 5.49, 4.61, 3.13 Å, respectively) were displayed for the compound rutin while crocin established seven hydrogen bonds (5.13, 4.94, 5.66, 3.93, 4.11, 4.33, 6.48Å respectively) with GLN220 (1 bond each on each chain), GLN22, VAL21 (1bond each on each chain), GLU188, ARG191 of the 1ETH ([Table 1](#tbl1){ref-type="table"}). A diagram of the 2D interaction is illustrated in [Fig. 10](#fig10){ref-type="fig"}.Fig. 102D interactions between 1ETH and 1) orlistat, 2) EGCG, 3) ECG, 4) EC, 5) caffeine, 6) rutin, 7) crocin.Fig. 10

4. Discussion {#sec4}
=============

To date, there are treatment regimens available for obesity, including lifestyle modifications (e.g. diet control and physical exercise) ([@bib9]; [@bib26]; [@bib33]; [@bib37]), pharmacotherapies (eg. orlistat, liraglutide and lorcaserin.) ([@bib9]; [@bib33]) and bariatric surgeries (e.g. restrictive procedures or malabsorptive procedures) ([@bib26]). However, the treatment outcomes are usually disappointing as a result of failing to maintain lifestyle modifications ([@bib37]) or dropping out from treatments due to disturbing side effects such as faecal incontinence and abdominal pain ([@bib9]; [@bib20]; [@bib33]). Therefore, herbal supplements including medicinal plant extracts and Chinese herbal medicine as well and their associated natural products, have a long history of assisting obese individuals with weight management have become popular alternatives ([@bib11]; [@bib12]; [@bib37]).

Anti-obesity mechanisms of herbal supplements include increasing energy expenditure, appetite suppression or blocking lipids absorption ([@bib37]). The inhibition of lipase that interferes with the digestion of lipids and targets the gastrointestinal tract directly has been used as one of the promising strategies for weight reduction and management ([@bib37]). Pancreatic (triacylglycerol) lipase is a key lipolytic enzyme secreted by the pancreas ([@bib5]). Inactivation of PL has been proven to have anti-obesity effects by forming a covalent bond with gastric and pancreatic lipase in the gut and stopping lipases turning dietary fat into absorbable monoglycerides and free fatty acids. Therefore weight loss can be induced due to a reduction of fat absorption and an attenuation of caloric absorption ([@bib5]).

Different enzymatic assays are available to detect the inhibitory potential of herbal supplements, natural plants or medicinal extracts ([@bib5]; [@bib22]). In our pancreatic lipase inhibition study, a fluorescence-based assay was selected as it is sensitive than the methods such as spectrophotometry ([@bib5]). 4MUO, an oleate ester was used as the substrate and the presence of its highly-fluorescent hydrolysed product 4 MU was proportional to lipase activities ([@bib5]). Our data has shown that green tea exhibited the strongest inhibitory activity (89%). The RCM-107 formula, which exhibited an IC~50~ value of 7.17 ± 0.69 μg/mL, presented a slightly lower inhibition rate (88%) than green tea but this difference was statistically insignificant. The inhibition rate of the RCM-107 formula and other 3 single herbal granules, including green tea, *Sophorae flos* (80%) and *Gardeniae fructus* (74%) were higher than the known, irreversible lipase inhibitor orlistat (73%). However, only the RCM-107 formula and green tea are considered as statistically significant containing more potent inhibitors than orlistat at a concentration of 100 μg/mL. In addition, lotus leaf (68%), *Alismatis rhizome* (55%) and *Cassiae semen* (46%) showed less potent inhibitory effects than the above-mentioned herbs, but the reduction of lipase activities was statistically significant. On the other hand, *Poria* and *Plantaginis semen* displayed non-significant effects on suppressing pancreatic lipase, which may suggest that these 2 herbs have no inhibitory effects on lipase at this concentration (100 μg/mL). Overall, the strongest inhibitors of pancreatic lipase identified from the samples in this study were from green tea and the RCM-107 formula, slightly more potent than orlistat when they were assayed under the same conditions.

Several previous studies ([@bib6]; [@bib7]; [@bib35]; [@bib43]) have identified the lipase inhibitory effects of polyphenols and flavonoids presented in the eight crude herbal ingredients from the RCM-107 formula. In a study by [@bib7], they investigated EGCG from green tea as a potent pancreatic lipase inhibitor with an IC~50~ of 1.8 ± 0.57 μM while 4MUO was also used as a substrate ([@bib7]). ECG, one of the polyphenols that exhibited strong inhibitory action on pancreatic lipase had a IC~50~ value of 1.046 μg/mL ([@bib43]) while EC showed weak inhibitory effects with an IC~50~ of \>500 μM ([@bib7]). The flavonoid, rutin present in lotus leaf and *Sophorae flos* was suggested as a weak lipase inhibitor with an IC~50~ over 81.9 μM ([@bib6]). In addition, an *in vivo* study conducted by [@bib35] reported the inhibitory effects of crocin on pancreatic lipase and showed its potential of decreasing lipase activates in a dose-dependent manner with an IC~50~ of 28.63 μM/L using emulsion as a substrate ([@bib35]). Quercetin has previously been reported as strong lipase inhibitor with an IC~50~ value of 21.5 μM ± 9.4 ([@bib25]). Moreover, Q3*O*G from lotus leaf (IC~50~ \> 50 μg/mL) ([@bib43]), chrysophanol from *Cassia semen* ([@bib18]) and alisol B acetate from *Alismatis rhizoma* ([@bib23]) has been mentioned in the literature for its possible lipase inhibition or weight reduction effects. Caffeine, on the other hand, has been reported to have no effects on pancreatic lipase ([@bib43]), which corresponds to our molecular docking results due to its lowest binding affinity with the target enzyme.

Ten compounds mentioned above were used as authentic standards to efficiently identify their presence in the RCM-107 formula and related single herbs via HPTLC profiling, which is an efficient, chemical profiling technique for the efficient analysis of small molecules (i.e. natural products) in biological matrices such as Chinese herbal extracts ([@bib38]). It is rapid as well as cost-effective and the results can be directly displayed in the form of images in real-time. The authentic standards and samples are analysed in parallel, which allows the results to be evaluated in under 10 min by comparing the *Rf* of the authentic standard(s) to that either present or absent in the sample ([@bib15]). HPTLC has also found applications in the fraudulence, adulteration, authentication, quality control of raw materials, food and herbal products ([@bib15]). The presence of 6 standards in the RCM-107 formula and related single herbal granules, including flavonoids (rutin); polyphenols (EGCG, ECG, EC and caffeine) and crocin were identified using HPTLC. However, quercetin, Q3*O*G, alisol B acetate and chrysophanol were not detected (or potentially below the limits of detection of HPTLC) in the tested samples ([Table 2](#tbl2){ref-type="table"}). It is also likely that the absence of these desired compounds may be due to compound degradation during the extraction process ([@bib41]). The oxidation process and stability of some compounds could be prone to changes in pH ([@bib30]). For instance, alisol B acetate contains an unstable component epoxy heterocyclic, which initiates a ring-opening reaction and generates alisol A 24-acetate under acidic conditions ([@bib44]).Table 2HPTLC results sumamrising the presence or absence of active compounds present in target samples.Table 210 StandardsRCM-107 formulaGreen tea*Cassia semenSophorae flos*Lotus leaf*Gardeniae fructusAlismatis rhizoma*EGCG✓✓ECG✓✓EC✓✓Rutin✓✓Caffeine✓✓Crocin✓✓Alisol B acetateXXQuercetinX✓ChrysphanolXXQ3*O*GX✓

The six compounds identified in HPTLC were selected for molecular docking studies, aiming to elucidate the interactions and the best binding modes between selected ligands (i.e. small molecule compounds) and targets (i.e. macromolecules) ([@bib1]). PyRx, an open-source molecular docking software was selected to conduct the computer-based analysis in order to obtain the optimal binding modes (bound conformation) and corresponding binding affinities ([@bib10]). In this study, the binding energy between ligands and the target protein as well as the profiles of protein-ligand interaction were predicted. Our docking results suggested that crocin, EC, EGCG, ECG exhibited stronger binding affinity in 1ETH than rutin, orlistat and caffeine, which may correlate with their biological activities ([@bib1]).

Rutin and caffeine showed lower or no lipase inhibitory activities in previous enzyme assays, which is consistent with their predicted weaker binding affinity presented in the docking results ([@bib6]; [@bib43]). On the other hand, the known inhibitory potency of EGCG is inconsistent with the present molecular docking predictions. As mentioned earlier, EGCG is a more potent lipase inhibitor than ECG, EC and crocin according to their IC~50~ values reported in previous *in vitro* experiments ([@bib7]; [@bib35]; [@bib43]), our docking results, however, demonstrated a weaker binding affinity of EGCG than crocin and EC. Thus, predicted docking binding affinity is likely to be only one of several factors that need to be taken into account in order to accurately predict inhibitory activity. Possible reasons that contribute to the weaker binding affinity of EGCG include: docking results can be affected by protonation state or proton exchange as a result of environmental differences ([@bib14]). In addition, other factors such as pH and molecular environment of particular compounds can affect the interactions between protein and ligands ([@bib14]).

Inspection of the ligand-protein interactions in details revealed that HIS152, ASP80 and GLY77 were found as common residues that have formed hydrogen bonds with EGCG, EC and the known inhibitor orlistat at the same interaction site ([Fig. 11](#fig11){ref-type="fig"}), which may explain the role of the enzyme inhibition of EGCG and EC ([@bib7]). Although ECG has also been found to interact with the same amino acid residues HIS152 and GLY77 as orlistat, its active site was on the other chain of 1ETH. In addition, rutin and crocin showed lipase inhibitory activities in the assay studies as mentioned earlier ([@bib6]; [@bib35]), and they were found to interact with amino acids at a site when distinct from that which bind the known inhibitor orlistat. Further experimental studies are warranted to fully elucidate the roles of the residues HIS152, ASP80 and GLY77 in their interactions with rutin and crocin.Fig. 11Amino acids interact with orlistat, EGCG and EC, their common residues have been circled and highlighted in red.Fig. 11

5. Conclusion {#sec5}
=============

In this study, the RCM-107 formula was found to be a potent lipase inhibitor, which could suppress lipid absorption and result in weight loss. The majority of ingredients from this formula also showed their lipase suppressing activities. The presence of 6 active weight-loss compounds has been effectively identified in the studied formula and related single granules. In addition, EGCG and EC have been found to interact with 1ETH at the same site as orlistat, forming hydrogen bonds with HIS152, ASP80 and GLY77 amino acid residues, which can be considered as markers of important areas in the ligand-binding site and may explain the details of their roles in inhibiting pancreatic lipase. Although further investigation is necessary for a more comprehensive understanding of the RCM-107 formula for weight loss, our preliminary results have provided new knowledge into the mechanisms and use of the studied herbal formula and single herbal granules in weight reduction. HPTLC was used as rapid chemical profiling tool (under 10 min) to identify either the absence or presence of the target compound in the formula. The quantification of the identified compounds along with linearity ([@bib16]), limits of detection ([@bib16]) will be carried out in future studies using either HPTLC and/or High performance liquid chromatography.
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